Remove Networking Remove Patients Remove Safety
article thumbnail

Unlocking the Potential of Healthcare Claims Data Part II: Optimizing Network Performance

Clarify Health

This is part two of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. Rewarding superior service fosters a competitive, quality-driven environment.

article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evaluating the financial impact of high-performing hospital networks

Clarify Health

It’s harder than ever for hospital networks to thrive — today’s healthcare landscape is characterized by shrinking operating margins, rising costs, and labor shortages. Landscape of provider performance benchmarking The landscape of hospital network performance benchmarking can be challenging to navigate.

article thumbnail

Are timely access and robust safety mutually exclusive?

pharmaphorum

And how can regulators balance timely access with robust safety? Cancer patients in Europe wait an average of almost eight months longer for access to breakthrough medications than their American counterparts. The FDA approves new cancer treatments in half the time of the EMA – but does faster mean better?

Safety 98
article thumbnail

Personalizing the Cancer Patient Journey

Pharma Marketing Network

The patient care team supplies an abundance of information, although sifting through brochures and online resources can be daunting for the patient and their caregiver. 1 The marketer’s goal is to design easy-to-follow patient guidelines while conforming to med-legal language. Meeting Patients Where They Are.

Patients 130
article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.

Safety 59
article thumbnail

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

Legacy MEDSearch

In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. Patients were to remain off antihypertensive medications throughout the two months of follow-up unless specified BP criteria were exceeded.